190 related articles for article (PubMed ID: 34117181)
1. Impact of Comorbidities and Antiplatelet Regimen on Platelet Reactivity Levels in Patients Undergoing Transcatheter Aortic Valve Implantation.
Trejo-Velasco B; Tello-Montoliu A; Cruz-González I; Moreno R; Baz-Alonso JA; Salvadores PJ; Romaguera R; Molina-Navarro E; Paredes-Galán E; Fernández-Barbeira S; Ortiz-Saez A; Bastos-Fernandez G; De Miguel-Castro A; Figueiras-Guzman A; Iñiguez-Romo A; Jimenez-Diaz VA
J Cardiovasc Pharmacol; 2021 Sep; 78(3):463-473. PubMed ID: 34117181
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Platelet REACtivity After Transcatheter Aortic Valve Replacement: The REAC-TAVI Trial.
Jimenez Diaz VA; Tello-Montoliu A; Moreno R; Cruz Gonzalez I; Baz Alonso JA; Romaguera R; Molina Navarro E; Juan Salvadores P; Paredes Galan E; De Miguel Castro A; Bastos Fernandez G; Ortiz Saez A; Fernandez Barbeira S; Raposeiras Roubin S; Ocampo Miguez J; Serra Peñaranda A; Valdes Chavarri M; Cequier Fillat A; Calvo Iglesias F; Iñiguez Romo A
JACC Cardiovasc Interv; 2019 Jan; 12(1):22-32. PubMed ID: 30621974
[TBL] [Abstract][Full Text] [Related]
3. Influence of Valve Type and Antiplatelet Regimen on Platelet Reactivity After TAVI: Subanalysis of the REAC-TAVI Trial.
Trejo-Velasco B; Cruz-González I; Tello-Montoliu A; Baz-Alonso JA; Salvadores PJ; Moreno R; Romaguera R; Molina-Navarro E; Paredes-Galán E; De-Miguel-Castro A; Bastos-Fernandez G; Ortiz-Saez A; Fernández-Barbeira S; Iñiguez-Romo A; Jimenez-Diaz VA
J Invasive Cardiol; 2020 Dec; 32(12):446-452. PubMed ID: 32771996
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Ticagrelor Versus Clopidogrel on Cerebrovascular Microembolic Events and Platelet Inhibition during Transcatheter Aortic Valve Implantation.
Vavuranakis MA; Kalantzis C; Voudris V; Kosmas E; Kalogeras K; Katsianos E; Oikonomou E; Siasos G; Aznaouridis K; Toutouzas K; Stasinopoulou M; Tountopoulou A; Bei E; Moldovan CM; Vrachatis D; Iakovou I; Papaioannou TG; Tousoulis D; Leucker TM; Vavuranakis M
Am J Cardiol; 2021 Sep; 154():78-85. PubMed ID: 34243938
[TBL] [Abstract][Full Text] [Related]
5. The role of platelet reactivity assessment in dual antiplatelet prophylaxis after transcatheter aortic valve implantation.
Czerwińska-Jelonkiewicz K; Witkowski A; Dąbrowski M; Piotrowski W; Hryniewiecki T; Stępińska J
Arch Cardiovasc Dis; 2018 Apr; 111(4):233-245. PubMed ID: 29126843
[TBL] [Abstract][Full Text] [Related]
6. Platelet reactivity in patients undergoing transcatheter aortic valve implantation.
Orvin K; Eisen A; Perl L; Zemer-Wassercug N; Codner P; Assali A; Vaknin-Assa H; Lev EI; Kornowski R
J Thromb Thrombolysis; 2016 Jul; 42(1):11-8. PubMed ID: 26695072
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter Aortic Valve Implantation Induces Transient Drop in Platelet Reactivity.
Ostojic Z; Bulum J; Samardzic J; Pavasovic S; Sipus D; Safradin I; Reskovic Luksic V; Skoric B; Separovic Hanzevacki J; Milicic D
J Cardiovasc Pharmacol; 2021 Aug; 78(2):263-268. PubMed ID: 34029272
[TBL] [Abstract][Full Text] [Related]
8. Impact of high on-treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT-DES substudy.
Rubin GA; Kirtane AJ; Chen S; Redfors B; Weisz G; Baber U; Zhang Y; Stuckey TD; Witzenbichler B; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Mazzaferri EL; Mehran R; Ali ZA; Ben-Yehuda O; Stone GW
Catheter Cardiovasc Interv; 2020 Oct; 96(4):793-801. PubMed ID: 31721430
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of high on-treatment (aspirin and clopidogrel) platelet reactivity in patients with critical limb ischemia.
Clavijo LC; Al-Asady N; Dhillon A; Matthews RV; Caro J; Tun H; Rowe V; Shavelle DM
Cardiovasc Revasc Med; 2018 Jul; 19(5 Pt A):516-520. PubMed ID: 29221961
[TBL] [Abstract][Full Text] [Related]
10. Effect of ticagrelor versus clopidogrel on platelet reactivity measured by thrombelastography in patients with minor stroke or TIA.
Yang Y; Chen W; Pan Y; Yan H; Meng X; Liu L; Wang Y; Wang Y
Aging (Albany NY); 2020 Oct; 12(20):20085-20094. PubMed ID: 33065552
[TBL] [Abstract][Full Text] [Related]
11. Platelet function testing guided antiplatelet therapy reduces cardiovascular events in Chinese patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: The PATROL study.
You J; Li H; Guo W; Li J; Gao L; Wang Y; Geng L; Wang X; Wan Q; Zhang Q
Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():598-605. PubMed ID: 31957972
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D levels and platelet reactivity in diabetic patients receiving dual antiplatelet therapy.
Verdoia M; Pergolini P; Nardin M; Rolla R; Negro F; Kedhi E; Suryapranata H; Marcolongo M; Carriero A; De Luca G;
Vascul Pharmacol; 2019 Sep; 120():106564. PubMed ID: 31176855
[TBL] [Abstract][Full Text] [Related]
13. High on-treatment platelet reactivity in transcatheter aortic valve implantation patients.
Polzin A; Schleicher M; Seidel H; Scharf RE; Merx MW; Kelm M; Zeus T
Eur J Pharmacol; 2015 Mar; 751():24-7. PubMed ID: 25641745
[TBL] [Abstract][Full Text] [Related]
14. Switch to Ticagrelor in critical limb ischemia antiplatelet study (STT-CLIPS).
Clavijo LC; Dhillon A; Al-Asady N; Matthews RV; Caro J; Tun H; Rowe V; Shavelle DM
Cardiovasc Revasc Med; 2018; 19(3 Pt B):319-323. PubMed ID: 29329963
[TBL] [Abstract][Full Text] [Related]
15. Aspirin Versus Clopidogrel as Single Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry.
Kobari Y; Inohara T; Saito T; Yoshijima N; Tanaka M; Tsuruta H; Yashima F; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Yamawaki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Watanabe Y; Yamamoto M; Hayashida K
Circ Cardiovasc Interv; 2021 May; 14(5):e010097. PubMed ID: 34003663
[TBL] [Abstract][Full Text] [Related]
16. Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation.
Brouwer J; Nijenhuis VJ; Delewi R; Hermanides RS; Holvoet W; Dubois CLF; Frambach P; De Bruyne B; van Houwelingen GK; Van Der Heyden JAS; Toušek P; van der Kley F; Buysschaert I; Schotborgh CE; Ferdinande B; van der Harst P; Roosen J; Peper J; Thielen FWF; Veenstra L; Chan Pin Yin DRPP; Swaans MJ; Rensing BJWM; van 't Hof AWJ; Timmers L; Kelder JC; Stella PR; Baan J; Ten Berg JM
N Engl J Med; 2020 Oct; 383(15):1447-1457. PubMed ID: 32865376
[TBL] [Abstract][Full Text] [Related]
17. Intensified P2Y12 inhibition for high-on treatment platelet reactivity.
Mshelbwala FS; Hugenberg DW; Kreutz RP
J Thromb Thrombolysis; 2020 Oct; 50(3):619-627. PubMed ID: 32152791
[TBL] [Abstract][Full Text] [Related]
18. DAPT Plus Cilostazol is Better Than Traditional DAPT or Aspirin Plus Ticagrelor as Elective PCI for Intermediate-to-Highly Complex Cases: Prospective, Randomized, PRU-Based Study in Taiwan.
Chen YC; Lin FY; Lin YW; Cheng SM; Lin RH; Chuang CL; Sheu JS; Chen SM; Chang CC; Tsai CS
Am J Cardiovasc Drugs; 2019 Feb; 19(1):75-86. PubMed ID: 30467686
[TBL] [Abstract][Full Text] [Related]
19. Aspirin platelet reactivity on platelet function and clinical outcome in minor stroke or transient ischemic attack.
Xu Y; Chen W; Jiang L; Wang Y; Zhao X; Liu L; Yao D; Guo L; Wang Y; Pan Y; Wang Y
J Stroke Cerebrovasc Dis; 2022 Sep; 31(9):106683. PubMed ID: 35914511
[TBL] [Abstract][Full Text] [Related]
20. Effect of adjunctive dipyridamole to DAPT on platelet function profiles in stented patients with high platelet reactivity. The result of the ACCEL-DIP Study.
Park Y; Jeong YH; Tantry US; Ahn JH; Kim KH; Koh JS; Park JR; Hwang SJ; Kwak CH; Hwang JY; Gurbel PA
Thromb Haemost; 2014 Dec; 112(6):1198-208. PubMed ID: 25182660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
